Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions.
BACKGROUND: Increased rates for failure in leishmaniasis antimony treatment have been recently recognized worldwide. Although several risk factors have been identified there is no clinical score to predict antimony therapy failure of cutaneous leishmaniasis. METHODS: A case control study was conduct...
Saved in:
Main Authors: | Cristian Valencia (Author), Jorge Arévalo (Author), Jean Claude Dujardin (Author), Alejandro Llanos-Cuentas (Author), François Chappuis (Author), Mirko Zimic (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite Load.
by: Milagros Suárez, et al.
Published: (2015) -
Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar, India.
by: Anette Stauch, et al.
Published: (2012) -
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019) -
First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.
by: Cesar Miranda-Verastegui, et al.
Published: (2009) -
Risk factors for antimony treatment failure in American Cutaneous Leishmaniasis in Northwestern-Argentina.
by: María F García-Bustos, et al.
Published: (2021)